Table 5 Median (range) dosimetric results for organs at risk and healthy tissue

Medullar canal

D_2% (Gy)

32.6 (30.1-39.0)

25.3 (23.0-34.6)

0.003*

PRV medullar canal

D_2% (Gy)

34.3 (31.6-40.4)

27.2 (24.1-35.1)

0.003*

I parotid gland

V_26Gy (%)

31.1 (0–42.6)

33.8 (0–45.9)

0.812

D_mean (Gy)

19.9 (0–24.4)

19.5 (0–25.8)

0.812

C parotid gland

V_26Gy (%)

0 (0–49.3)

0 (0–47.3)

0.85

D_mean (Gy)

6.6 (0–28.1)

4.3 (0–27.2)

0.032*

I submaxillary gland

D_mean (Gy)

36.1 (15.4-44.6)

34.5 (24.7-44.6)

0.623

C submaxillary gland

D_mean (Gy)

33.1 (3.4-41.9)

29.1 (1.5-39.6)

0.041*

Mandible

D_2% (Gy)

35.6 (1.4-52.2)

42.6 (0.9-58.0)

0.01*

Oral cavity

D_mean (Gy)

17.2 (0.5-27.4)

17.8 (0.5-32.2)

0.075

Larynx

D_2% (Gy)

60.8 (49.2-64.9)

60.7 (43.6-65.0)

0.209

D_mean (Gy)

45.9 (10.8-62.5)

39.2 (25.0-62.6)

0.638

Esophagus

D_2% (Gy)

60.9 (47.7-63.7)

57.5 (41.6-64.7)

0.049*

I brachial plexus

D_2% (Gy)

62.7 (44.1-67.4)

62.5 (46.4-64.6)

0.209

C brachial plexus

D_2% (Gy)

54.4 (29.7-58.5)

54.2 (26.8-55.1)

0.308

ID body

(Joules)

138.5 (54.9-242.3)

149.5 (72.5-271.0)

0.008*

NTID

(Joules)

117.0 (47.0-201.6)

124.6 (64.7-226.3)

0.008*